pubmed-article:20844879 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C0443224 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C0312418 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C1956267 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C0036667 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C2348480 | lld:lifeskim |
pubmed-article:20844879 | lifeskim:mentions | umls-concept:C1957174 | lld:lifeskim |
pubmed-article:20844879 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:20844879 | pubmed:dateCreated | 2011-6-27 | lld:pubmed |
pubmed-article:20844879 | pubmed:abstractText | The need for new treatment options for acute myeloid leukemia (AML) is increasing. AS602868 is a novel investigational drug with reported activity on AML cells. | lld:pubmed |
pubmed-article:20844879 | pubmed:language | eng | lld:pubmed |
pubmed-article:20844879 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20844879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20844879 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20844879 | pubmed:month | Jul | lld:pubmed |
pubmed-article:20844879 | pubmed:issn | 1432-0843 | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:DumontetCharl... | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:DreanoMichelM | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:PlesaAdrianaA | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:JordheimLars... | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:KeimeCélineC | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:VendrellJulie... | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:HerveauStépha... | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:Cros-PerrialE... | lld:pubmed |
pubmed-article:20844879 | pubmed:author | pubmed-author:DemangelDelph... | lld:pubmed |
pubmed-article:20844879 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20844879 | pubmed:volume | 68 | lld:pubmed |
pubmed-article:20844879 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20844879 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20844879 | pubmed:pagination | 97-105 | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:meshHeading | pubmed-meshheading:20844879... | lld:pubmed |
pubmed-article:20844879 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:20844879 | pubmed:articleTitle | Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868. | lld:pubmed |
pubmed-article:20844879 | pubmed:affiliation | Université Lyon 1, ISPB, Lyon 69003, France. jordheim@yahoo.com | lld:pubmed |
pubmed-article:20844879 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20844879 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |